Related Experiment Video
Updated: Aug 1, 2025
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Pancreatic Tumor-Targeting Stemsome Therapeutics
Jun-Young Park1, Jun Young Park2, Yong-Gyu Jeong2
1Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, 21999, South Korea.
Abstract:
Owing to the intrinsic ability of stem cells to target the tumor environment, stem-cell-membrane-functionalized nanocarriers can target and load active anticancer drugs. In this work, a strategy that focuses on stem cells that self-target pancreatic cancer cells is developed. In particular, malignant deep tumors such as pancreatic cancer cells, one of the intractable tumors that currently have no successful clinical strategy, are available for targeting and destruction. By gaining the targeting ability of stem cells against pancreatic tumor cells, stem cell membranes can encapsulate nano-polylactide-co-glycolide loaded with doxorubicin to target and reduce deep pancreatic tumor tissues. Considering the lack of known target proteins on pancreatic tumor cells, the suggested platform technology can be utilized for targeting any malignant tumors in which surface target receptors are unavailable.
Insights
Stem cell membranes functionalized onto nanocarriers effectively target pancreatic cancer. This novel approach delivers anticancer drugs like doxorubicin to deep tumors, offering a new strategy for intractable cancers.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Pancreatic cancer is a challenging tumor with limited treatment options.
- Stem cells possess inherent tumor-targeting capabilities.
- Developing effective drug delivery systems for deep-seated tumors remains a significant challenge.
Purpose of the Study:
- To develop a novel nanocarrier system for targeting pancreatic cancer.
- To leverage stem cell membranes for enhanced tumor homing.
- To investigate the potential of stem-cell-membrane-functionalized nanocarriers for delivering anticancer drugs to deep tumors.
Main Methods:
- Stem cell membranes were used to functionalize nano-polylactide-co-glycolide (PLGA) nanocarriers.
- Doxorubicin was loaded into the functionalized nanocarriers.
- The targeting ability of these nanocarriers against pancreatic cancer cells was evaluated.
- The efficacy of the drug-loaded nanocarriers in reducing deep pancreatic tumor tissues was assessed.
Main Results:
- Stem-cell-membrane-functionalized nanocarriers demonstrated effective targeting of pancreatic cancer cells.
- The nanocarriers successfully delivered doxorubicin to deep tumor tissues.
- The strategy showed potential for treating intractable pancreatic tumors.
Conclusions:
- Stem-cell-membrane-functionalized nanocarriers represent a promising platform for pancreatic cancer therapy.
- This approach offers a potential strategy for targeting tumors lacking specific surface receptors.
- The technology could be extended to target other malignant tumors.
More Related Videos
05:08Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
